News from Novo Nordisk Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

04 May, 2017, 10:45 ET Heart attacks, strokes and other major health events play key role in driving older Americans with obesity to address their weight

A statistically significant greater proportion of older people with obesity (PwO) (16%) than younger ones (12%) reported that a specific medical...


03 May, 2017, 10:15 ET Novo Nordisk Launches Xultophy® 100/3.6 (insulin degludec and liraglutide injection) in the United States

Novo Nordisk, a world leader in diabetes care, today announced the availability of its new combination therapy Xultophy® 100/3.6 (insulin degludec...


27 Apr, 2017, 11:06 ET Novo Nordisk Receives FDA Approval of Saxenda® (liraglutide) injection 3 mg Label Update Including Long-Term Safety and Efficacy Data from 3-Year Trial

Novo Nordisk today announced that the US Food and Drug Administration (FDA) approved an updated product label for Saxenda® (liraglutide) injection...


17 Apr, 2017, 09:33 ET Novo Nordisk Invites the Community to Unmask Everyday Heroes in Recognition of World Hemophilia Day

Not every hero wears a cape or has super powers. In the hemophilia community, many perform heroic acts to help knock down barriers and unite each...


09 Mar, 2017, 09:04 ET Novo Nordisk Named on the FORTUNE 100 Best Companies to Work For® List for Ninth Consecutive Year

Novo Nordisk in the U.S. has ranked #73 on the FORTUNE "100 Best Companies to Work For®" list, marking the ninth consecutive year it has been...


09 Feb, 2017, 09:33 ET Great Place to Work® and Fortune Name Novo Nordisk as one of the country's best workplaces for giving back

Great Place to Work® and Fortune today recognized Novo Nordisk in the United States as one of the country's "Best Workplaces for Giving Back." Novo...


19 Dec, 2016, 14:00 ET Novo Nordisk Receives FDA Approval of Tresiba® (insulin degludec injection 100 U/mL, 200 U/mL) for Use in Children and Adolescents With Diabetes

Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for...


07 Dec, 2016, 09:36 ET Novo Nordisk recognized for diversity and inclusion

Novo Nordisk in the United States is honored to have been recognized for demonstrating a strategic and long-term commitment to fostering diversity...


05 Dec, 2016, 09:42 ET Novo Nordisk Files for Regulatory Approval of Once-Weekly Semaglutide with the FDA for the Treatment of Type 2 Diabetes

Novo Nordisk today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for semaglutide, a...


21 Nov, 2016, 19:51 ET Novo Nordisk Receives FDA Approval for Xultophy® 100/3.6 (insulin degludec and liraglutide injection)

Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) approved the New Drug Application...


14 Nov, 2016, 08:05 ET One World Trade Center to Glow Blue in Honor of World Diabetes Day Tonight

Tonight, on World Diabetes Day, the spire of One World Trade Center will be lit in blue, the official color of diabetes, to raise awareness of the...


14 Nov, 2016, 02:00 ET Novo Nordisk forlænger og udvider program for børn med type 1-diabetes i udviklingslande

Novo Nordisk har besluttet at forlænge sit Changing Diabetes® in Children-program med fire år - et program, som giver børn med type 1-diabetes i...


14 Nov, 2016, 02:00 ET Novo Nordisk prolonge son programme afin de prendre en charge jusqu'à 20 000 enfants atteints de diabète dans les pays en voie de développement

Aujourd'hui, Novo Nordisk a annoncé une prolongation de quatre ans de son programme intitulé Changing Diabetes® in Children. Spécialement conçu...


14 Nov, 2016, 02:00 ET Novo Nordisk erweitert sein Hilfsprogramm auf 20.000 Kinder mit Diabetes in Entwicklungsländern

Novo Nordisk gab heute eine Verlängerung seines Engagements "Changing Diabetes® in Children" um vier Jahre bekannt. Das Hilfsprogramm bietet...


14 Nov, 2016, 02:00 ET Novo Nordisk Expands Programme to Reach 20,000 Children with Diabetes in Developing Countries

Today, Novo Nordisk announced a four-year extension of its Changing Diabetes® in Children programme which provides access to diabetes care and...


14 Nov, 2016, 02:00 ET Novo Nordisk amplía su programa humanitario para llegar a 20.000 niños con diabetes en los países en desarrollo

Novo Nordisk ha anunciado una ampliación de cuatro años en su programa Changing Diabetes® in Children que proporciona acceso al cuidado de la...


14 Nov, 2016, 02:00 ET Novo Nordisk amplía su programa para cubrir a 20 mil niños con diabetes en los países en desarrollo

Novo Nordisk anunció hoy una extensión de cuatro años de su programa para cambiar la diabetes en los niños "Changing Diabetes® in...


14 Nov, 2016, 02:00 ET Novo Nordisk expande programa para alcançar 20.000 crianças com diabetes em países em desenvolvimento

A Novo Nordisk acaba de anunciar uma extensão de quatro anos em seu programa Changing Diabetes® in Children (Mudando o Diabetes em Crianças,...


01 Nov, 2016, 04:00 ET New Data Show Post-Meal Hyperglycaemia is Associated with a Negative Impact on Quality of Life for People with Diabetes

This material is intended for global medical media only. For journalistic assessment and preparation before publication. Abstract: 69477 New...


27 Oct, 2016, 09:00 ET Novo Nordisk to present eight abstracts at the 4th annual ObesityWeek in New Orleans, LA

Novo Nordisk, a global leader in obesity care, today announced that data from eight abstracts, including six posters and two oral presentations,...


27 Sep, 2016, 12:48 ET Working Mother names Novo Nordisk Inc. one of its "100 Best Companies"

 Working Mother magazine today recognized Novo Nordisk Inc. as one of the 2016 "Working Mother 100 Best Companies." Novo Nordisk, a world...


16 Sep, 2016, 02:31 ET Semaglutide reduced major cardiovascular events by 26% in adults with type 2 diabetes at high cardiovascular risk

This material is intended for global medical media only.   For journalistic assessment and preparation before...


15 Sep, 2016, 12:37 ET Great Place to Work® and Fortune name Novo Nordisk as one of the country's best workplaces for women

Novo Nordisk is one of the 2016 Best Workplaces for Women, according to global research and consulting firm Great Place to Work® and...


08 Sep, 2016, 14:16 ET Novo Nordisk Inc. issues voluntary nationwide recall of six batches of GlucaGen® HypoKit® (glucagon [rDNA origin] for injection) due to detached needles on the syringe in the kit

 Novo Nordisk Inc. is recalling six batches of the GlucaGen® HypoKit® in the U.S. due to two customer complaints from the UK and...


15 Aug, 2016, 08:30 ET Hip-Hop Legend Rev Run and Wife Justine Simmons Unveil Experiential Photo Exhibit with Novo Nordisk Depicting the Millions of Americans at Risk of Diabetes

 Novo Nordisk today unveiled the "Am I at Risk?" traveling exhibit as an extension of its Ask.Screen.Know.® program urging adults to know...